相关实验视频

Updated: Jan 18, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

慢性阻塞性肺病中的生物标志物的预后价值:综合性审查

Yunpeng Xu¹, Lei Zhang¹, Lei Zhu²

¹The First Clinical Medical College of Lanzhou University, Lanzhou, People's Republic of China.

International journal of chronic obstructive pulmonary disease

|September 10, 2025

概括

生物标志物和多式数据改善慢性阻塞性肺病 (COPD) 预后预测. 本综述探讨了它们用于个性化COPD管理和临床应用的用途.

科学领域:

肺部医学肺部医学
生物标志物发现发现
呼吸系统研究呼吸系统研究

背景情况:

慢性阻塞性肺病 (COPD) 呈现出显著的异质性和复杂性.
传统的临床评估在预后预测和COPD患者个性化管理方面面临挑战.

研究的目的:

审查COPD预后的关键生物标志物.
讨论多生物标志物模型和多模式数据集成的应用和潜力.
评估这些方法在临床实践中对精确的COPD管理的转化价值.

主要方法:

科学文献的叙述性审查.
对COPD预后生物标志物的系统讨论.
分析多种生物标志物预测模型和多式联运数据整合策略.

主要成果:

生物标志物探索为精确的COPD评估提供了新的途径.
多种生物标志物模型和多种模式的数据集成可以提高预测的准确性和可靠性.
这些综合策略显示了个性化COPD管理的巨大潜力.

结论:

生物标志物和综合数据策略对于推进COPD精准医学至关重要.
需要进一步的研究和临床验证,以最大限度地提高它们的翻译价值.
这一综述为改善COPD预后和患者护理提供了科学基础.

关键词:

生物标志物生物标志物慢性阻塞性慢性阻塞性预后预测预测预测肺部疾病是一种肺部疾病.

更多相关视频

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Published on: April 12, 2024

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

相关概念视频

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: